These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. FGFR3-TACCs3 Fusions and Their Clinical Relevance in Human Glioblastoma. Gött H; Uhl E Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955806 [TBL] [Abstract][Full Text] [Related]
23. FGFR1/3 tyrosine kinase fusions define a unique molecular subtype of non-small cell lung cancer. Wang R; Wang L; Li Y; Hu H; Shen L; Shen X; Pan Y; Ye T; Zhang Y; Luo X; Zhang Y; Pan B; Li B; Li H; Zhang J; Pao W; Ji H; Sun Y; Chen H Clin Cancer Res; 2014 Aug; 20(15):4107-14. PubMed ID: 24850843 [TBL] [Abstract][Full Text] [Related]
24. Absence of FGFR3-TACC3 rearrangement in hematological malignancies with numerical chromosomal alteration. Banella C; Ginevrino M; Catalano G; Fabiani E; Falconi G; Divona M; Curzi P; Panetta P; Voso MT; Noguera NI Hematol Oncol Stem Cell Ther; 2021 Jun; 14(2):163-168. PubMed ID: 32199932 [TBL] [Abstract][Full Text] [Related]
25. FGFR3-TACC3 is an oncogenic fusion protein in respiratory epithelium. Best SA; Harapas CR; Kersbergen A; Rathi V; Asselin-Labat ML; Sutherland KD Oncogene; 2018 Nov; 37(46):6096-6104. PubMed ID: 29991799 [TBL] [Abstract][Full Text] [Related]
26. PGC1α regulates mitochondrial oxidative phosphorylation involved in cisplatin resistance in ovarian cancer cells via nucleo-mitochondrial transcriptional feedback. Shen L; Zhou L; Xia M; Lin N; Ma J; Dong D; Sun L Exp Cell Res; 2021 Jan; 398(1):112369. PubMed ID: 33220258 [TBL] [Abstract][Full Text] [Related]
27. FGFR3-TACC3 cancer gene fusions cause mitotic defects by removal of endogenous TACC3 from the mitotic spindle. Sarkar S; Ryan EL; Royle SJ Open Biol; 2017 Aug; 7(8):. PubMed ID: 28855393 [TBL] [Abstract][Full Text] [Related]
28. The diabetes medication canagliflozin promotes mitochondrial remodelling of adipocyte via the AMPK-Sirt1-Pgc-1α signalling pathway. Yang X; Liu Q; Li Y; Tang Q; Wu T; Chen L; Pu S; Zhao Y; Zhang G; Huang C; Zhang J; Zhang Z; Huang Y; Zou M; Shi X; Jiang W; Wang R; He J Adipocyte; 2020 Dec; 9(1):484-494. PubMed ID: 32835596 [TBL] [Abstract][Full Text] [Related]
29. Strong FGFR3 staining is a marker for FGFR3 fusions in diffuse gliomas. Granberg KJ; Annala M; Lehtinen B; Kesseli J; Haapasalo J; Ruusuvuori P; Yli-Harja O; Visakorpi T; Haapasalo H; Nykter M; Zhang W Neuro Oncol; 2017 Sep; 19(9):1206-1216. PubMed ID: 28379477 [TBL] [Abstract][Full Text] [Related]
30. RNAi technology targeting the Parker Kerrigan BC; Ledbetter D; Kronowitz M; Phillips L; Gumin J; Hossain A; Yang J; Mendt M; Singh S; Cogdell D; Ene C; Shpall E; Lang FF Neurooncol Adv; 2020; 2(1):vdaa132. PubMed ID: 33241214 [TBL] [Abstract][Full Text] [Related]
31. DNA methylation analysis of glioblastomas harboring FGFR3-TACC3 fusions identifies a methylation subclass with better patient survival. Wu Z; Lopes Abath Neto O; Bale TA; Benhamida J; Mata D; Turakulov R; Abdullaev Z; Marker D; Ketchum C; Chung HJ; Giannini C; Quezado M; Pratt D; Aldape K Acta Neuropathol; 2022 Jul; 144(1):155-157. PubMed ID: 35567606 [No Abstract] [Full Text] [Related]
32. Dual targeting of FGFR3 and ERBB3 enhances the efficacy of FGFR inhibitors in FGFR3 fusion-driven bladder cancer. Weickhardt AJ; Lau DK; Hodgson-Garms M; Lavis A; Jenkins LJ; Vukelic N; Ioannidis P; Luk IY; Mariadason JM BMC Cancer; 2022 May; 22(1):478. PubMed ID: 35501832 [TBL] [Abstract][Full Text] [Related]
33. Genetic and epigenetic landscape of IDH-wildtype glioblastomas with FGFR3-TACC3 fusions. Mata DA; Benhamida JK; Lin AL; Vanderbilt CM; Yang SR; Villafania LB; Ferguson DC; Jonsson P; Miller AM; Tabar V; Brennan CW; Moss NS; Sill M; Benayed R; Mellinghoff IK; Rosenblum MK; Arcila ME; Ladanyi M; Bale TA Acta Neuropathol Commun; 2020 Nov; 8(1):186. PubMed ID: 33168106 [TBL] [Abstract][Full Text] [Related]
37. Propofol induces impairment of mitochondrial biogenesis through inhibiting the expression of peroxisome proliferator-activated receptor-γ coactivator-1α. Qin J; Li Y; Wang K J Cell Biochem; 2019 Oct; 120(10):18288-18297. PubMed ID: 31190345 [TBL] [Abstract][Full Text] [Related]
38. Is reliance on mitochondrial respiration a "chink in the armor" of therapy-resistant cancer? Wolf DA Cancer Cell; 2014 Dec; 26(6):788-795. PubMed ID: 25490445 [TBL] [Abstract][Full Text] [Related]